JP2016511278A5 - - Google Patents

Download PDF

Info

Publication number
JP2016511278A5
JP2016511278A5 JP2015562212A JP2015562212A JP2016511278A5 JP 2016511278 A5 JP2016511278 A5 JP 2016511278A5 JP 2015562212 A JP2015562212 A JP 2015562212A JP 2015562212 A JP2015562212 A JP 2015562212A JP 2016511278 A5 JP2016511278 A5 JP 2016511278A5
Authority
JP
Japan
Prior art keywords
hydroxybutyrate
process according
poly
alcohol
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015562212A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016511278A (ja
JP6110959B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/055156 external-priority patent/WO2014140308A1/en
Publication of JP2016511278A publication Critical patent/JP2016511278A/ja
Publication of JP2016511278A5 publication Critical patent/JP2016511278A5/ja
Application granted granted Critical
Publication of JP6110959B2 publication Critical patent/JP6110959B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015562212A 2013-03-14 2014-03-14 (r)−3−ヒドロキシブチル(r)−3−ヒドロキシブチレートの製造方法 Expired - Fee Related JP6110959B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361783167P 2013-03-14 2013-03-14
US61/783,167 2013-03-14
PCT/EP2014/055156 WO2014140308A1 (en) 2013-03-14 2014-03-14 Process for producing (r)-3-hydroxybutyl (r)-3-hydroxybutyrate

Publications (3)

Publication Number Publication Date
JP2016511278A JP2016511278A (ja) 2016-04-14
JP2016511278A5 true JP2016511278A5 (cg-RX-API-DMAC7.html) 2016-07-14
JP6110959B2 JP6110959B2 (ja) 2017-04-05

Family

ID=50336299

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015562212A Expired - Fee Related JP6110959B2 (ja) 2013-03-14 2014-03-14 (r)−3−ヒドロキシブチル(r)−3−ヒドロキシブチレートの製造方法

Country Status (13)

Country Link
US (2) US11566268B2 (cg-RX-API-DMAC7.html)
EP (1) EP2984066B1 (cg-RX-API-DMAC7.html)
JP (1) JP6110959B2 (cg-RX-API-DMAC7.html)
KR (1) KR102265842B1 (cg-RX-API-DMAC7.html)
CN (1) CN105246870A (cg-RX-API-DMAC7.html)
AU (1) AU2014230120B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015023334B1 (cg-RX-API-DMAC7.html)
CA (1) CA2905225C (cg-RX-API-DMAC7.html)
DK (1) DK2984066T3 (cg-RX-API-DMAC7.html)
ES (1) ES2623368T3 (cg-RX-API-DMAC7.html)
GB (1) GB2515603B (cg-RX-API-DMAC7.html)
SG (1) SG11201507685UA (cg-RX-API-DMAC7.html)
WO (1) WO2014140308A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060280721A1 (en) 2003-06-03 2006-12-14 The Gov Of Usa Represented By Secretary Of Dpt Of Nutritional supplements and therapeutic compositions comprising (r)-3- hydroxybutyrate derivatives
DK2240017T3 (da) 2008-01-04 2019-06-17 Univ Oxford Innovation Ltd Ketonlegemer og ketonlegemsestere som blodlipid-sænkende midler
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
GB201002983D0 (en) 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
US9579302B2 (en) 2012-11-05 2017-02-28 Tdeltas Ketone bodies to protect tissues from damage by ionizing radiation
GB201304467D0 (en) 2013-03-12 2013-04-24 Tdeltas Ltd Compound for use in protecting skin
BR112015023334B1 (pt) 2013-03-14 2021-05-18 Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services processo para produção de (r)-3hidroxibutil (r)-3-hidroxibutirato
US9255059B2 (en) 2013-08-02 2016-02-09 Eastman Chemical Company Method for producing an alkyl 3-hydroxybutyrate
US9388114B2 (en) 2013-08-02 2016-07-12 Eastman Chemical Company Compositions including an alkyl 3-hydroxybutyrate
US9163202B2 (en) 2013-08-02 2015-10-20 Eastman Chemical Company Aqueous cleaning compositions including an alkyl 3-hydroxybutyrate
US9249378B2 (en) 2013-08-02 2016-02-02 Eastman Chemical Company Aqueous cleaning compositions having enhanced properties
US20190023632A1 (en) * 2016-01-06 2019-01-24 Archer Daniels Midland Company Process for producing 1,3-butanediol and for optionally further producing (r)-3-hydroxybutyl (r)-3-hydroxybutyrate
AU2017278099B2 (en) 2016-06-07 2021-03-11 Ithaca College Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same
US20180057846A1 (en) 2016-08-30 2018-03-01 KetoneAid Inc. Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy
GB201710229D0 (en) 2017-06-27 2017-08-09 Tdeltas Ltd Compounds for new use
BR112020001285A2 (pt) 2017-07-21 2020-07-28 Buck Institute For Research On Aging s-enantiômeros de beta-hidroxibutirato e butanodiol e métodos para sua utilização
US11760963B2 (en) 2017-08-23 2023-09-19 KetoneAid Inc. Ketogenic beer and alcoholic beverage mixture containing non-racemic ethyl 3-hydroxybutyrate and/or 1,3 butanediol
GB201715654D0 (en) 2017-09-27 2017-11-08 Tdeltas Ltd Method of treatment
JP7039940B2 (ja) 2017-11-09 2022-03-23 トヨタ自動車株式会社 車両制御装置
WO2019147503A1 (en) * 2018-01-25 2019-08-01 Buck Institute For Research On Aging Synthesis of 3-hydroxybutyryl 3-hydroxybutyrate and related compounds
GB2575623B (en) 2018-06-04 2022-10-26 Tdeltas Ltd 3-hydroxybutyrate esters for treating cancer cachexia
GB2577723A (en) 2018-10-04 2020-04-08 Tdeltas Ltd Compounds for new use
US12415774B2 (en) * 2019-01-17 2025-09-16 Ketolipix Therapeutics Gmbh Polyol-based esters of hydroxycarboxylic acids
GB201918657D0 (en) 2019-12-17 2020-01-29 Tdeltas Ltd Compounds for new use
US12396974B2 (en) 2020-03-27 2025-08-26 KetoneAid Ketone ester as a therapeutic treatment of Covid-19 and related viral infections
CN113045416B (zh) * 2021-03-23 2023-08-18 南京纽邦生物科技有限公司 一种(r)-3-羟基丁酰-(r)-3-羟基丁酯的制备方法
BR112023024355A2 (pt) 2021-06-28 2024-02-06 Phb Ind S/A Processo para produzir misturas opticamente ativas de (r)-3-hidroxibutirato e (r)-3-hidroxivalerato e método para tratar um indivíduo tendo uma doença metabólica
WO2025143117A1 (ja) * 2023-12-28 2025-07-03 株式会社カネカ バイオマス由来ヒドロキシアルカン酸エステルの製造方法

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1141293B (de) * 1958-08-22 1962-12-20 Iromedica A G Verfahren zur Herstellung von o-[Bis-(4, 4'-oxyphenyl)-methyl]-benzyl-alkohol (Phenolphthalol)
US3984566A (en) 1974-02-25 1976-10-05 Scott Eugene J Van Method of alleviating the symptoms of dandruff
IT1051853B (it) 1975-01-07 1981-05-20 Basf Ag Butandiol 1.3 3 mono 3 idros sibutirrati butandiol 1.3 1mono 3 idrossibutirrati e processi per la loro preparazione
US4380549A (en) 1975-07-23 1983-04-19 Scott Eugene J Van Topical treatment of dry skin
JPS54138126A (en) 1978-04-17 1979-10-26 Ajinomoto Co Inc Remedy for diabetes
WO1987003806A1 (en) 1985-12-18 1987-07-02 Veech Richard L Parenteral nutrition therapy with amino acids
JPH0755158B2 (ja) 1986-10-30 1995-06-14 チッソ株式会社 光学活性エステルの製造法
US4916074A (en) 1986-10-30 1990-04-10 Chisso Corporation Process for producing optically active compounds
JP2579779B2 (ja) 1987-10-08 1997-02-12 日本車輌製造株式会社 飼料の製造法
BE1001209A3 (fr) 1987-11-19 1989-08-22 Solvay Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol.
JPH0383950A (ja) 1989-08-28 1991-04-09 Kanegafuchi Chem Ind Co Ltd グリセリド誘導体およびその製造法
JP2873497B2 (ja) 1990-09-03 1999-03-24 理化学研究所 脂質代謝調節剤
EP0537113A1 (en) 1991-10-10 1993-04-14 SANDOZ NUTRITION Ltd. Energy supplementary food
JP2884123B2 (ja) 1992-01-17 1999-04-19 高砂香料工業株式会社 生分解性光学活性ポリマー、その中間体オリゴマー、およびそれらの製造方法
US5654266A (en) 1992-02-10 1997-08-05 Chen; Chung-Ho Composition for tissues to sustain viability and biological functions in surgery and storage
US5281691A (en) 1992-06-19 1994-01-25 Eastman Kodak Company Poly(3-hydroxyalkanoates)
US5468507A (en) 1993-07-13 1995-11-21 Czap; Al F. Composition containing a desired flavoring agent and medium chain triglycerides
JP3193542B2 (ja) 1993-09-08 2001-07-30 カネボウ株式会社 皮膚老化防止化粧料
WO1995009144A1 (en) 1993-09-30 1995-04-06 Eastman Chemical Company Nutritive water soluble glycerol esters of hydroxy butyric acid
DE4427492A1 (de) 1994-08-03 1996-02-08 Boehringer Mannheim Gmbh Verfahren zur Analyse einer medizinischen Probe unter Vermeidung von Störbeiträgen aufgrund von Hämolyse
EP0696605B1 (de) 1994-08-10 2000-09-20 Peter Neuenschwander Biokompatibles Blockcopolymer
JPH08191664A (ja) 1995-01-12 1996-07-30 Yoshihide Hagiwara 新規コーヒー抽出物の製造法
EP0816316A4 (en) * 1995-03-10 1999-06-02 Nitto Chemical Industry Co Ltd Process for producing 1,2-ethanediol derivatives
US6306828B1 (en) 1995-04-06 2001-10-23 Baxter International, Inc. Enantiomerically-enhanced nutritional energy substrates
JP4598203B2 (ja) 1995-12-01 2010-12-15 ビーティージー・インターナショナル・リミテッド 脳機能改善剤
US6126953A (en) 1996-08-19 2000-10-03 The Procter & Gamble Company Fragrance delivery systems for personal care articles
JPH10175855A (ja) 1996-10-16 1998-06-30 Taisho Pharmaceut Co Ltd 肉体疲労改善剤
US20090253781A1 (en) 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
DK1017379T3 (en) 1997-03-17 2015-02-16 Btg Int Ltd Therapeutic compositions comprising ketone compounds and precursors thereof
US6323237B1 (en) 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US6316038B1 (en) 1997-03-17 2001-11-13 Btg International Limited Therapeutic compositions
JPH10265378A (ja) 1997-03-25 1998-10-06 Ofutekusu:Kk 角膜上皮損傷治療剤
US6232346B1 (en) 1997-03-27 2001-05-15 Michael J. Sole Composition for improvement of cellular nutrition and mitochondrial energetics
JP3869071B2 (ja) 1997-05-14 2007-01-17 三栄源エフ・エフ・アイ株式会社 甘味食品
WO1998051302A1 (en) 1997-05-15 1998-11-19 University Of Washington Composition and methods for treating alzheimer's disease and other amyloidoses
US6727258B2 (en) 1997-10-29 2004-04-27 King Pharmaceutical Research & Development, Inc. Allosteric adenosine receptor modulators
GB9723590D0 (en) 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
DE69922206T2 (de) 1998-07-22 2005-11-24 Metabolix, Inc., Cambridge Nahrungs- und therapeutische verwendung von hydroxyalkanoat oligomere
JP2002524506A (ja) 1998-09-15 2002-08-06 ビーティージー・インターナショナル・リミテッド 治療用組成物(ii)
EP1194582A1 (de) * 1999-07-09 2002-04-10 Forschungszentrum Jülich Gmbh Verfahren zur reduktion von keto-carbonsäuren und deren estern
ES2323940T3 (es) 2000-05-01 2009-07-28 Accera, Inc. Uso de trigliceridos de cadena media para el tratamiento y prevencion de la enfermedad de alzheimer.
US20070179197A1 (en) 2000-05-01 2007-08-02 Accera, Inc. Compositions and methods for improving or preserving brain function
WO2002006368A2 (en) 2000-07-14 2002-01-24 Metabolix, Inc. Polyurethanes obtained from hydroxyalkanoates and isocyanates
US6970737B1 (en) 2000-09-13 2005-11-29 Ge Medical Systems Information Technologies, Inc. Portable ECG device with wireless communication interface to remotely monitor patients and method of use
AUPR177300A0 (en) 2000-11-29 2000-12-21 Centre For Molecular Biology And Medicine Therapeutic methods
US20050129783A1 (en) 2001-04-19 2005-06-16 Mccleary Edward L. Composition and method for treatment of neurophysiological conditions and maintenance of neurophysiological health
GB0118931D0 (en) 2001-08-02 2001-09-26 Oxford Biosensors Ltd Voltammetric ion-selective biosensor
AU2002357355A1 (en) * 2001-12-18 2003-06-30 Metabolix, Inc. Methods of making intermediates from polyhydroxyalkanoates
GB0130684D0 (en) 2001-12-21 2002-02-06 Oxford Biosensors Ltd Micro-band electrode
DE20205184U1 (de) 2002-03-27 2002-12-19 Bartz, Volker, 35440 Linden Blutfettsenker zur oralen Einnahme
GB0211449D0 (en) 2002-05-17 2002-06-26 Oxford Biosensors Ltd Analyte measurement
US8996090B2 (en) 2002-06-03 2015-03-31 Exostat Medical, Inc. Noninvasive detection of a physiologic parameter within a body tissue of a patient
CN1483355A (zh) 2002-09-16 2004-03-24 岚 高 抗疲劳饮料配方
DK1641444T3 (en) 2003-06-02 2016-06-27 Isis Innovation Treatment of muscle fatigue
US20060280721A1 (en) 2003-06-03 2006-12-14 The Gov Of Usa Represented By Secretary Of Dpt Of Nutritional supplements and therapeutic compositions comprising (r)-3- hydroxybutyrate derivatives
JP2005247821A (ja) 2004-02-06 2005-09-15 Ophtecs Corp 炎症性サイトカインの産生を抑制するための眼科用組成物
DE102004007029A1 (de) 2004-02-12 2005-09-08 Consortium für elektrochemische Industrie GmbH Verfahren zur enantioselektiven Reduktion von Ketoverbindungen durch Enzyme
US20050181275A1 (en) 2004-02-18 2005-08-18 Jang Bor Z. Open electrochemical cell, battery and functional device
WO2006020137A2 (en) 2004-07-16 2006-02-23 Ketocytonyx Inc. Oligomeric compounds
US20060057691A1 (en) 2004-09-15 2006-03-16 Karunakaran Narasimhan Process for the extraction of polyhydroxyalkanoates from biomass
US8124063B2 (en) 2004-10-25 2012-02-28 Conopco, Inc. Method for moisturizing human skin using dihydroxypropyltri(C1-C3 alkyl) ammonium salts
GB0427145D0 (en) 2004-12-10 2005-01-12 Ketocytonyx Inc Compositions for use in surgery
ITTO20040918A1 (it) 2004-12-29 2005-03-29 Luigi Ambrosio Idrogel polimerici superassorbenti biodegradabili e procedimento per la loro preparazione
EP1915144A4 (en) 2005-06-20 2009-08-19 Accera Inc METHOD FOR REDUCING OXIDATIVE DAMAGE AND IMPROVING MITOCHONDRIA EFFICIENCY
CA2631264A1 (en) 2005-11-29 2007-06-07 Basf Se Process for esterifying or transesterifying side chains in polymers
EP2500017B1 (en) 2006-04-03 2017-09-06 Accera, Inc. Use of ketogenic compounds for treatment of age-associated memory impairment
EP2004160B1 (en) 2006-04-12 2012-09-19 Unilever PLC Oral composition with an antiageing effect on the skin
US7807718B2 (en) 2006-06-30 2010-10-05 Sami A. Hashim Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose
JP5030553B2 (ja) 2006-11-24 2012-09-19 有限会社ノーベル医学研究所 ドライマウスおよび/または唾液分泌障害を処置するための医薬
RU2446208C9 (ru) 2006-12-19 2012-11-10 Басф Се Применение и способ профилактики или лечения кариеса, вызванного mutans streptococci, отличных от streptococcus mutans
WO2008119032A1 (en) 2007-03-27 2008-10-02 Perscitus Biosciences, Llc Compositions and methods for protecting cells from toxic exposures
JP5065742B2 (ja) 2007-04-18 2012-11-07 三栄源エフ・エフ・アイ株式会社 香味の発現性及び持続性が改善された調味食品
CA2685380A1 (en) 2007-05-14 2008-11-20 Neuera Pharmaceuticals, Inc. Inhibitors of acetyl-coa carboxylase for treatment of neuronal hypometabolism
WO2009023357A2 (en) 2007-05-25 2009-02-19 University Of Rochester Curcumin derivatives and their use as radioprotectors
DK2240017T3 (da) 2008-01-04 2019-06-17 Univ Oxford Innovation Ltd Ketonlegemer og ketonlegemsestere som blodlipid-sænkende midler
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
PL3296284T3 (pl) * 2008-08-21 2022-06-13 The Government Of The United States Of America, As Repres. By The Secretary Of Health And Human Services, Nat. Inst. Of Health Nieterapeutyczne zastosowanie estru hydroksymaślanowego
CN102449157B (zh) * 2009-04-16 2015-06-03 伊希斯创新有限公司 使用短乳杆菌醇脱氢酶通过酶促对映选择性还原来制备(3r)-羟丁基(3r)-羟基丁酸酯的方法
GB201002983D0 (en) 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
FR2958154B1 (fr) 2010-04-01 2012-06-08 Oreal Procede de soin et/ou de maquillage des rides
AU2012219321C1 (en) 2011-02-17 2016-02-04 Armis Biopharma, Inc. Compositions comprising peroxy alpha-ketocarboxylic acid and methods for producing and using the same
WO2012113415A1 (en) 2011-02-24 2012-08-30 N.V. Nutricia Ketogenic diet composition for the treatment of chemo therapy and/or radiation therapy patients
GB201206192D0 (en) 2012-04-05 2012-05-23 Tdeltas Ltd Ketone bodies and ketone body esters and for maintaining or improving muscle power output
US9895331B2 (en) 2012-07-23 2018-02-20 The University Of Tokyo Prophylactic and/or therapeutic agent for radiation damage
US9579302B2 (en) 2012-11-05 2017-02-28 Tdeltas Ketone bodies to protect tissues from damage by ionizing radiation
GB201304467D0 (en) * 2013-03-12 2013-04-24 Tdeltas Ltd Compound for use in protecting skin
BR112015023334B1 (pt) 2013-03-14 2021-05-18 Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services processo para produção de (r)-3hidroxibutil (r)-3-hidroxibutirato
RU2659386C2 (ru) 2013-03-19 2018-06-29 Юниверсити Оф Соус Флорида Композиции и способы, используемые для повышения и поддержания кетоза
GB201314127D0 (en) 2013-08-07 2013-09-18 Tdeltas Ltd Ketone body and ketone body ester for reducing muscle breakdown

Similar Documents

Publication Publication Date Title
JP2016511278A5 (cg-RX-API-DMAC7.html)
IN2014DN06491A (cg-RX-API-DMAC7.html)
JP2014034682A5 (cg-RX-API-DMAC7.html)
JP2016536324A5 (cg-RX-API-DMAC7.html)
JP2014512451A5 (cg-RX-API-DMAC7.html)
JP2016523852A5 (cg-RX-API-DMAC7.html)
JP2013536648A5 (cg-RX-API-DMAC7.html)
JP2015532645A5 (cg-RX-API-DMAC7.html)
JP2016521748A5 (cg-RX-API-DMAC7.html)
WO2015051298A3 (en) Alcohol dehydrogenase variants
JP2013054465A5 (cg-RX-API-DMAC7.html)
MX2013007135A (es) Proceso para la conversion de materia prima que contiene carbohidrato.
JP2015514699A5 (cg-RX-API-DMAC7.html)
JP2016060674A5 (cg-RX-API-DMAC7.html)
JP2015536288A5 (cg-RX-API-DMAC7.html)
WO2014101902A8 (zh) 一种提高酶促油脂制备生物柴油产率的方法
RU2016107486A (ru) Способ получения рифаксимина к
MX2015016793A (es) Procedimiento para producir un producto que contiene fructosido.
JP2012017322A5 (cg-RX-API-DMAC7.html)
JP2011148087A5 (cg-RX-API-DMAC7.html)
JP2017510543A5 (cg-RX-API-DMAC7.html)
CN203768267U (zh) 一种甲醇氢氯化生产一氯甲烷装置中利用反应热的装置
PH12015502670A1 (en) Raw sugar and ethanol production method using selective fermentation
BR112017010642A2 (pt) leveduras fermentativas de etanol altamente eficientes
JP2015500313A5 (cg-RX-API-DMAC7.html)